Hillstream BioPharma, Inc.
Hillstream BioPharma, Inc. (HILS) Stock Overview
Explore Hillstream BioPharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.2M
P/E Ratio
-0.02
EPS (TTM)
$-0.70
ROE
-5.50%
HILS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Hillstream BioPharma, Inc. (HILS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.08.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 4.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.